Industry Developments

In what could usher in a paradigm shift in the drug sector, UK-based pharmaceutical giant

In what could usher in a paradigm shift in the drug sector, UK-based pharmaceutical giant

In what could usher in a paradigm shift in the drug sector, UK-based pharmaceutical giant

The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition... 2008-03-14

The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition... 2008-03-14

The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition... 2008-03-14

The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition... 2008-03-14

Switzerland's medical device market is highly developed and was worth approximately US$4.1bn in 2007. By 2012 the market should reach a value of US$5.2bn, representing a compound... 2008-03-13

Italian drugmaker

A new transition agreement regarding pharmaceutical prices has come into effect in the Netherlands.